Failure to achieve clinical response · Patients with active Crohn's disease
Antibiotic probably leads to lower failure to achieve clinical response compared with placebo (moderate certainty).
1 finding from 1 review
Failure to maintain endoscopic remission · Patients with active Crohn's disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in adverse events compared with placebo (high certainty).
1 finding from 1 review
Serious adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with active Crohn's disease
Antibiotic showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Change in BCVA (lower logMAR indicate better vision) · People with toxoplasma retinochoroiditis
1 finding from 1 review
or more recurrences of retinochoroiditis · People with toxoplasma retinochoroiditis
Antibiotic probably leads to lower or more recurrences of retinochoroiditis compared with no treatment (moderate certainty).
1 finding from 1 review
Improvement in intraocular inflammation · People with toxoplasma retinochoroiditis
Antibiotic showed no clear difference in improvement in intraocular inflammation compared with no treatment (low certainty).
1 finding from 1 review
Size of lesion · People with toxoplasma retinochoroiditis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · People with toxoplasma retinochoroiditis
Antibiotic showed no clear difference in adverse events compared with no treatment (low certainty).
1 finding from 1 review
Time to next exacerbation · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
1 finding from 1 review
FVC (% predicted) Change from baseline · adults and children with cystic fibrosis (during acute exacerbations of lung disease)
1 finding from 1 review
Neonatal sepsis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in neonatal sepsis compared with placebo (low certainty).
1 finding from 1 review
Chorioamnionitis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic probably leads to lower chorioamnionitis compared with placebo (moderate certainty).
1 finding from 1 review
Postpartum endometritis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in postpartum endometritis compared with placebo (low certainty).
1 finding from 1 review
Mortality and morbidity prior to discharge (Neonatal intensive care admissions) · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in mortality and morbidity prior to discharge (Neonatal intensive care… compared with placebo (low certainty).
1 finding from 1 review
Side effects · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of admission to neonatal intensive care unit · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found